Similar companies
| Company | Transaction Value | |
|---|---|---|
 |
OcugenOCGN |
-$5.5M |
 |
Gilead SciencesGILD |
-$4.04B |
 |
AmgenAMGN |
-$189M |
 |
Editas MedicineEDIT |
-$7M |
 |
Crispr TherapeuticsCRSP |
-$177M |
Are Oragenics Insiders Buying or Selling?
Oragenics (OGEN) has had no reported insider transactions in the past 90 days. The most recent was Fred Telling, who sold 210 shares at $0.94 on December 12, 2025.
Insider trading patterns can signal confidence or concern from the people who know the company best. AltIndex tracks insider transactions as one of 25+ alternative data signals in the OGEN AI Score. For government officials trading this stock, see OGEN congressional trading.
Who’s Trading Oragenics Stock?
| Insider | Activity | Trades | Last Trade |
|---|---|---|---|
| Odyssey Health, Inc. | Sold $53,000 | 3 | Jun 18, 2025 |
| Fred Telling | Sold $1,700 | 3 | Dec 12, 2025 |
| ALAN DUNTON | Sold $24 | 1 | Dec 6, 2024 |
Recent Oragenics Insider Transactions
| Insider | Transaction Date | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| Fred Telling | Dec 12, 2025 | Sell | 210 | $0.94 | $200 |
| Fred Telling | Dec 12, 2025 | Sell | 210 | $0.94 | $200 |
| Odyssey Health, Inc. | Jun 18, 2025 | Sell | 5,044 | $4.26 | $21,000 |
| Odyssey Health, Inc. | Jun 17, 2025 | Sell | 2,000 | $4.46 | $8,900 |
| Odyssey Health, Inc. | Jun 16, 2025 | Sell | 5,000 | $4.45 | $22,000 |
| Fred Telling | Dec 6, 2024 | Sell | 3,597 | $0.36 | $1,300 |
| ALAN DUNTON | Dec 6, 2024 | Sell | 66 | $0.36 | $24 |
Frequently Asked Questions: Oragenics Insider Trading
Oragenics insiders have not reported any transactions in the past 90 days.
The most recent sale was by Fred Telling who sold 210 shares on December 12, 2025. View all transactions in the table on this page.
Insider buying is generally a stronger signal than insider selling, since insiders may sell for personal reasons (diversification, taxes) but typically buy only when they believe the stock is undervalued. AltIndex uses insider transaction patterns alongside 25+ other signals in the AI Score.
Odyssey Health, Inc. has sold the most OGEN stock in the last 2 years, with a total value of $53,000.
The total value of insider transactions for Oragenics in the last 2 years is negative, amounting to -$54,000. This suggests that insiders have predominantly sold shares, which could reflect various personal or financial considerations rather than a straightforward outlook on the company's future performance.
